Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Gross Margin of 67.61% for Q2 2026, up 4.61 percentage points from 63.00% a year earlier.
Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Eton Pharmaceuticals was 58.14%, down 1.26 percentage points year-over-year; for FY2025, it came in at 53.46%, down 6.55 percentage points from FY2024.
- Annual Gross Margin has declined for four consecutive years, though with a five-year change of +686.79 percentage points (FY2020 to FY2025).
- In prior years, Eton Pharmaceuticals' Gross Margin was 60.01% in FY2024 (-6.55 pp), 66.56% in FY2023 (-0.82 pp), 67.38% in FY2022 (-19.68 pp) and 87.05% in FY2021 (+720.38 pp).
- The Q2 2026 figure stands as the highest quarterly Gross Margin since Q2 2023.
- On a year-over-year basis, Gross Margin increased in four of the last seven quarters, with an average year-over-year change of -2.28 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2022, with a gain of 47.08 percentage points; the weakest was Q2 2022, with a drop of 31.63 percentage points.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.56 Bn | 25.41 Mn | 67.61% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.61% |
| Dec 31, 2025 | 61.56% |
| Sep 30, 2025 | 34.97% |
| Jun 30, 2025 | 63.00% |
| Mar 31, 2025 | 57.06% |
| Dec 31, 2024 | 55.60% |
| Sep 30, 2024 | 61.04% |
| Jun 30, 2024 | 62.00% |
| Mar 31, 2024 | 62.85% |
| Dec 31, 2023 | 49.64% |
| Sep 30, 2023 | 62.65% |
| Jun 30, 2023 | 80.70% |
| Mar 31, 2023 | 63.08% |
| Dec 31, 2022 | 74.84% |
| Sep 30, 2022 | 62.69% |
| Jun 30, 2022 | 62.69% |
| Mar 31, 2022 | 60.98% |
| Dec 31, 2021 | 93.89% |
| Sep 30, 2021 | 15.61% |
| Jun 30, 2021 | 94.33% |
Eton Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ETON&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();